Use of Pfizer Inc.’s COVID-19 oral antiviral treatment Paxlovid jumped 315 percent over the past four weeks, the U.S. Department of Health and Human Services said on May 17, as health officials try to address unexpectedly light demand.
The United States will allow baby formula imports from foreign makers that do not usually sell their products here, the Food and Drug Administration said on May 16, as it tries to ease a nationwide shortage that has left parents scrambling to feed their babies.
The White House is preparing for a scenario in which Congress fails to approve President Joe Biden’s request for additional COVID funds by reviewing old contracts to see if there is any money it can “claw back,” the president’s top COVID adviser said on May 12.
Biden marks 1 million Americans dead from COVID
Congress, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Coronavirus Mutations, Coronavirus Restrictions, Coronavirus surge, COVID-19 booster shots, COVID-19 Deaths, COVID-19 Infections, COVID-19 shots, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 treatment pill, COVID-19 vaccination rates, Covid-19 Variants, Joe Biden, Pandemics, Reuters Tally, SARS-CoV-2 virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Summits, United States, White House, White House coronavirus task forcePresident Joe Biden on May 12 commemorated the death of 1 million people in the United States from COVID-19, marking what he called “a tragic milestone” and urging Americans to “remain vigilant” amid the ongoing pandemic.
U.S. President Joe Biden’s administration is aiming to expand access to COVID-19 oral antiviral treatments like Pfizer Inc.’s Paxlovid by doubling the number of locations at which they are available, the White House said on April 26.
A second Global COVID-19 Summit will be held virtually during May for countries to discuss efforts to end the pandemic and prepare for future health threats, according to a joint statement on April 18.
White House launches COVID.gov amid push for more funds, booster shots
BNT162b2 (Pfizer and BioNTech), Congress, Coronavirus Cases, COVID-19 booster shots, COVID-19 Vaccines, Democrats, Funding, Health Officials, Immunocompromised, Joe Biden, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Websites, White HouseThe Biden administration on Wednesday launched a new website to provide a clearinghouse of information on COVID-19 as part of a continuing effort to prepare Americans to live with the coronavirus.
COVID-19 Update: Benefit of 4th Booster Could be Modest, New White House Coordinator
Appointments, Babies, BNT162b2 (Pfizer and BioNTech), Coronavirus Disease 2019 (COVID-19), COVID-19 booster shots, COVID-19 shots, COVID-19 transmission, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Dr. Anthony Fauci (Director), Emergency Use Authorization (EUA), FDA, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), National Institute of Allergy and Infectious Diseases (NIAID), Newborns, Omicron BA.2, People on the Move, Pfizer, White HouseWhile Moderna and Pfizer-BioNTech have submitted Emergency Use Authorization (EUA) requests for their COVID-19 vaccines, the data so far suggest the benefits of a fourth shot may be modest.
U.S. President Joe Biden on March 17 named public health expert Dr. Ashish Jha to replace White House COVID-19 coordinator Jeff Zients, who will leave his post in April, as the administration prepares for new COVID-19 variants and infection surges that could hit the country.
The U.S. government will run out of supplies of COVID-19 treatments known as monoclonal antibodies as soon as late May and will have to scale back plans to get more unless Congress provides more funding, the White House said on March 15.